Difference between revisions of "Comment Resolutions"
Jump to navigation
Jump to search
m |
(Added DWI Stage 3 Profile Title) |
||
Line 78: | Line 78: | ||
| 2021.12.16 | | 2021.12.16 | ||
| [[Media:QIBATechnicalConfirmationResolutions MRE.pdf| Technical Confirmation Resolutions 2022-02-14]] | | [[Media:QIBATechnicalConfirmationResolutions MRE.pdf| Technical Confirmation Resolutions 2022-02-14]] | ||
+ | | | ||
+ | |- | ||
+ | |MR Diffusion-Weighted Imaging (DWI) of the Apparent Diffusion Coefficient (ADC) 2022-12-15 | ||
+ | |Clinically Feasible | ||
+ | |2022.12.15 | ||
+ | |Clinically Feasible 2022-12-15 | ||
| | | | ||
|- | |- | ||
Line 92: | Line 98: | ||
| [[Media:QIBA PET Amyloid Profile changes.pdf| Technical Confirmation Resolutions, 2022-04-15]] | | [[Media:QIBA PET Amyloid Profile changes.pdf| Technical Confirmation Resolutions, 2022-04-15]] | ||
|- | |- | ||
− | | [[Media: | + | | [[Media:QIBA AmyloidPET 15June2017.pdf| PET Amyloid 2017-06-15]] |
|Public Comment | |Public Comment | ||
|2017.09.15 | |2017.09.15 |
Revision as of 17:38, 17 February 2023
Comments received during Public Comment, Clinically Feasible (formerly Technical) Confirmation, or during a Profile ballot, are reviewed by the originating Biomarker Committee.
Per the QIBA Process, committees record how each collected comment was resolved and those resolutions are posted here.